Format
Sort by

Send to

Choose Destination

Search results

Items: 12

1.

Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.

Smith KJ, Raviotta JM, DePasse JV, Brown ST, Shim E, Patricia Nowalk M, Zimmerman RK.

Am J Prev Med. 2016 May;50(5):600-8. doi: 10.1016/j.amepre.2015.12.010.

PMID:
26868283
2.

Quantifying influenza virus diversity and transmission in humans.

Poon LL, Song T, Rosenfeld R, Lin X, Rogers MB, Zhou B, Sebra R, Halpin RA, Guan Y, Twaddle A, DePasse JV, Stockwell TB, Wentworth DE, Holmes EC, Greenbaum B, Peiris JS, Cowling BJ, Ghedin E.

Nat Genet. 2016 Feb;48(2):195-200. doi: 10.1038/ng.3479.

3.

Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus.

Taft AS, Ozawa M, Fitch A, Depasse JV, Halfmann PJ, Hill-Batorski L, Hatta M, Friedrich TC, Lopes TJ, Maher EA, Ghedin E, Macken CA, Neumann G, Kawaoka Y.

Nat Commun. 2015 Jun 17;6:7491. doi: 10.1038/ncomms8491.

4.

Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.

Kerr PJ, Rogers MB, Fitch A, Depasse JV, Cattadori IM, Twaddle AC, Hudson PJ, Tscharke DC, Read AF, Holmes EC, Ghedin E.

J Virol. 2013 Dec;87(23):12900-15. doi: 10.1128/JVI.02060-13.

5.

Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations.

Kerr PJ, Rogers MB, Fitch A, Depasse JV, Cattadori IM, Hudson PJ, Tscharke DC, Holmes EC, Ghedin E.

J Virol. 2013 Nov;87(22):12080-9. doi: 10.1128/JVI.01923-13.

6.

Mammalian adaptation in the PB2 gene of avian H5N1 influenza virus.

Min JY, Santos C, Fitch A, Twaddle A, Toyoda Y, DePasse JV, Ghedin E, Subbarao K.

J Virol. 2013 Oct;87(19):10884-8. doi: 10.1128/JVI.01016-13.

7.

Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus.

Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, Stockwell T, Angus B, Cozzi-Lepri A, Delfino M, Dugan V, Dwyer DE, Freiberg M, Horban A, Losso M, Lynfield R, Wentworth DN, Holmes EC, Davey R, Wentworth DE, Ghedin E; INSIGHT FLU002 Study Group.; INSIGHT FLU003 Study Group..

J Virol. 2013 Jul;87(14):8064-74. doi: 10.1128/JVI.00240-13.

8.

Comparison of the respiratory microbiome in healthy nonsmokers and smokers.

Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM; Lung HIV Microbiome Project..

Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75. doi: 10.1164/rccm.201210-1913OC.

9.

Evolutionary history and attenuation of myxoma virus on two continents.

Kerr PJ, Ghedin E, DePasse JV, Fitch A, Cattadori IM, Hudson PJ, Tscharke DC, Read AF, Holmes EC.

PLoS Pathog. 2012;8(10):e1002950. doi: 10.1371/journal.ppat.1002950.

10.

Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.

Ghedin E, Holmes EC, DePasse JV, Pinilla LT, Fitch A, Hamelin ME, Papenburg J, Boivin G.

J Infect Dis. 2012 Nov 15;206(10):1504-11. doi: 10.1093/infdis/jis571.

11.

Brugia malayi gene expression in response to the targeting of the Wolbachia endosymbiont by tetracycline treatment.

Ghedin E, Hailemariam T, DePasse JV, Zhang X, Oksov Y, Unnasch TR, Lustigman S.

PLoS Negl Trop Dis. 2009 Oct 6;3(10):e525. doi: 10.1371/journal.pntd.0000525.

12.

A multi-reservoir model of influenza evolution.

Dreisigmeyer DW, Rosenfeld R, DePasse JV, Ghedin E, Price I, Clermont G.

J Crit Care. 2009 Sep;24(3):e33-e34. No abstract available.

Items per page

Supplemental Content

Loading ...
Support Center